dehydroaripiprazole

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2017
02420052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The CYP2D6*10(*10) allele that causes decreased CYP2D6 activity is present in Asians with a high frequency of approximately 50… (More)
  • figure 1
Is this relevant?
2010
2010
A simple and sensitive column-switching HPLC-UV method was developed for the simultaneous determination of aripiprazole, a novel… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
Aripiprazole, a relatively new antipsychotic drug, is metabolized by cytochrome P450 3A4 (CYP3A4) and CYP2D6 to an active… (More)
  • table 1
  • table 2
Is this relevant?
2008
2008
AIMS The aims of this study were to develop a combined population pharmacokinetic model for both aripiprazole and its active… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2008
2008
Aripiprazole, a novel antipsychotic drug, is metabolized by CYP3A4 and CYP2D6 forming mainly its active metabolite… (More)
Is this relevant?
2008
2008
Aripiprazole is a fairly new atypical antipsychotic substance. It acts as a partial D2- and 5-HT1A-agonist and as a 5-HT2A… (More)
Is this relevant?
2007
2007
Aripiprazole is an atypical antipsychotic drug which is metabolized by the polymorphic enzyme cytochrome P450 2D6 (CYP2D6). The… (More)
  • table 1
  • figure 1
Is this relevant?
2007
2007
Aripiprazole is a novel antipsychotic drug for the treatment of schizophrenia and schizoaffective disorders. In this study, a new… (More)
Is this relevant?
2007
2007
The objective of this study was to assess the pharmacokinetics of aripiprazole when coadministered with carbamazepine using an… (More)
Is this relevant?
2006
2006
Aripiprazole is a new atypical antipsychotic drug with a partial agonist activity at dopamine 2 and serotonin 1A receptors. The… (More)
Is this relevant?